GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,921,000 | -35.4% | 67,107 | -35.4% | 0.02% | -24.1% |
| Q1 2022 | $4,525,000 | +2.1% | 103,879 | +3.3% | 0.03% | 0.0% |
| Q4 2021 | $4,434,000 | +15.3% | 100,540 | -0.1% | 0.03% | +3.6% |
| Q3 2021 | $3,847,000 | -3.1% | 100,690 | +1.0% | 0.03% | -3.4% |
| Q2 2021 | $3,971,000 | +40.9% | 99,723 | +26.3% | 0.03% | +26.1% |
| Q1 2021 | $2,818,000 | -20.0% | 78,958 | -17.5% | 0.02% | -28.1% |
| Q4 2020 | $3,522,000 | +9.9% | 95,707 | +12.4% | 0.03% | -8.6% |
| Q3 2020 | $3,205,000 | +33.3% | 85,149 | +45.3% | 0.04% | +2.9% |
| Q2 2020 | $2,404,000 | +28.2% | 58,597 | +18.4% | 0.03% | +30.8% |
| Q1 2020 | $1,875,000 | -37.0% | 49,481 | -21.8% | 0.03% | -21.2% |
| Q4 2019 | $2,976,000 | +10.4% | 63,299 | +0.3% | 0.03% | +3.1% |
| Q3 2019 | $2,695,000 | -6.5% | 63,138 | -12.3% | 0.03% | -8.6% |
| Q2 2019 | $2,881,000 | +25.5% | 71,986 | +31.0% | 0.04% | +16.7% |
| Q1 2019 | $2,295,000 | +31.6% | 54,943 | +20.3% | 0.03% | +15.4% |
| Q4 2018 | $1,744,000 | -3.9% | 45,658 | +1.0% | 0.03% | +13.0% |
| Q3 2018 | $1,815,000 | -20.0% | 45,186 | -23.0% | 0.02% | -28.1% |
| Q2 2018 | $2,270,000 | -0.5% | 58,676 | +0.5% | 0.03% | +3.2% |
| Q1 2018 | $2,281,000 | +10.1% | 58,399 | -0.0% | 0.03% | +10.7% |
| Q4 2017 | $2,072,000 | -48.5% | 58,406 | -41.1% | 0.03% | -50.9% |
| Q3 2017 | $4,027,000 | +25.8% | 99,215 | +33.7% | 0.06% | +5.6% |
| Q2 2017 | $3,200,000 | -1.9% | 74,215 | -3.9% | 0.05% | -3.6% |
| Q1 2017 | $3,261,000 | +11.3% | 77,212 | +1.6% | 0.06% | +19.1% |
| Q4 2016 | $2,930,000 | +2.2% | 75,977 | +14.2% | 0.05% | -11.3% |
| Q3 2016 | $2,868,000 | 0.0% | 66,512 | +0.8% | 0.05% | -8.6% |
| Q2 2016 | $2,868,000 | +54.3% | 65,996 | +44.1% | 0.06% | +41.5% |
| Q1 2016 | $1,859,000 | -15.6% | 45,805 | -21.4% | 0.04% | -18.0% |
| Q4 2015 | $2,202,000 | -2.0% | 58,296 | 0.0% | 0.05% | -2.0% |
| Q3 2015 | $2,247,000 | +7.5% | 58,296 | +16.5% | 0.05% | +21.4% |
| Q2 2015 | $2,091,000 | -6.7% | 50,055 | +3.2% | 0.04% | -27.6% |
| Q1 2015 | $2,240,000 | +7.8% | 48,520 | -0.4% | 0.06% | +7.4% |
| Q4 2014 | $2,078,000 | +13.3% | 48,731 | +22.0% | 0.05% | +38.5% |
| Q3 2014 | $1,834,000 | +1.7% | 39,938 | +18.6% | 0.04% | 0.0% |
| Q2 2014 | $1,803,000 | +1.2% | 33,664 | +0.9% | 0.04% | -2.5% |
| Q1 2014 | $1,781,000 | +4.1% | 33,370 | +4.2% | 0.04% | -2.4% |
| Q4 2013 | $1,711,000 | +15.7% | 32,026 | +8.7% | 0.04% | +2.5% |
| Q3 2013 | $1,479,000 | +13.9% | 29,463 | +13.3% | 0.04% | -20.0% |
| Q2 2013 | $1,298,000 | – | 26,011 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |